|
Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective |
Segui MA, Crespo C, Cortes J, Lluch A, Brosa M, Becerra V, Chiavenna SM, Gracia A |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Segui MA, Crespo C, Cortes J, Lluch A, Brosa M, Becerra V, Chiavenna SM, Gracia A. Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective. Expert Review of Pharmacoeconomics and Outcomes Research 2014; 14(6): 889-899 Indexing Status Subject indexing assigned by NLM MeSH Algorithms; Antineoplastic Agents /economics /therapeutic use; Biomarkers, Tumor /genetics; Breast Neoplasms /drug therapy /economics /genetics; Chemotherapy, Adjuvant /economics; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Female; Gene Expression Profiling /economics; Genetic Predisposition to Disease; Genetic Testing /economics /methods; Health Care Costs; Humans; Markov Chains; Middle Aged; Models, Economic; National Health Programs /economics; Neoplasm Recurrence, Local; Phenotype; Precision Medicine /economics; Predictive Value of Tests; Quality of Life; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Spain; Time Factors; Treatment Outcome AccessionNumber 22014035876 Date bibliographic record published 20/11/2014 |
|
|
|